(En anglais) Chronic wounds: Recognising a new disease
Is it possible that treating chronic wounds as symptoms rather than as their own disease is leading to poorer results and worse clinical outcomes?
In this webinar, Gerhard Bothma and James McHale discuss this question and look at the clinical and economic burden of chronic wounds through this lens. Would changing the perspective on chronic wounds to consider them diseases themselves as opposed to symptoms change the outlook and outcomes? Some points explored during the webinar include:
- Chronic non-healing wounds are debilitating with high morbidity and mortality in a highly vulnerable patient population, yet they are not generally recognized as an actual disease.
- Despite extensive efforts to develop therapeutic strategies for effective treatment of chronic wounds, there are several reasons for the limited clinical success that has been achieved.
- Stakeholders in wound care must adopt a proactive integrated response that utilizes a broad network and takes full advantage of emerging technologies.
Gerhard Bothma
Global Director for Health Economics and Governmental Affairs, Mölnlycke Health Care, Sweden. Over the course of many years, Gerhard has acquired in-depth experience in health economics across both different device categories as well as different countries within Europe, the Middle East and Africa.
James McHale
Global Value-based Partnerships Manager, Mölnlycke Health Care. James has nearly a decade working in the medical devices industry, obtaining a broad procurement, NHS and industry perspective through roles in the public and private sector. His journey has identified a passion for value and understanding what these means to health care providers and clinicians.
